Home / Products
Henan Tongwei Medical Equipment Co., LtdCall us : +86 − −19139704654 // Email us : [email protected]
Henan Tongwei Medical Equipment Co., LtdCall us : +86 − −19139704654 // Email us : [email protected]
MIRCERA (methoxy polyethylene glycol-epoetin beta) injection for intravenous or subcutaneous use Initial U S Approval: 2007 WARNINGS: ESAs INCREASE THE RISK OF DEATH MYOCARDIAL INFARCTION STROKE VENOUS THROMBOEMBOLISM THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
Jun 22 2018Mircera is a prescription medication used to treat anemia associated with chronic kidney disease including patients on dialysis and patients not on dialysis Anemia is a condition that develops when your blood lacks enough healthy red blood cells Erythropoietin a primary growth factor for red blood cell production is produced in the kidney and released into the bloodstream
Jun 08 2018MIRCERA (methoxy polyethylene glycol-epoetin beta) LENGTH OF AUTHORIZATION: UP TO SIX MONTHS REVIEW CRITERIA: **Trial and failure to therapy of a preferred medication (e g Aranesp or Epogen) is required for each indication listed below: INITIAL THERAPY: Adults diagnosed with anemia due to chronic kidney disease (CKD) not on dialysis or
Mircera (methoxy polyethylene glycol-epoetin beta) 1 NAME OF THE MEDICINE Methoxy polyethylene glycol-epoetin beta 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Mircera 30 micrograms/0 3 mL solution for injection in pre-filled syringe Mircera 50 micrograms/0 3 mL solution for injection in pre-filled syringe
Mar 08 20181 Methoxy polyethylene glycol-epoetin (Mircera ) will be increased and decreased in 1-step or 2-step increments based on scale above 2 Mircera will be administered IV to HD patients and SC to PD patients 3 Mircera ceiling is 200 mcg every two weeks (or 3 0 mcg/kg/2 weeks whichever is lower)
Mircera (methoxy polyethylene glycol-epoetin beta) which is marketed by Vifor Pharma Mircera is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD) in (i) adult patients on dialysis and patients not on dialysis and (ii)
MIRCERA is a medicine produced by gene-technology Like the natural hormone erythropoietin MIRCERA increases the number of red blood cells and haemoglobin level in your blood 2 What you need to know before you use MIRCERA Do not use MIRCERA • if you are allergic to methoxy polyethylene glycol-epoetin beta or to any of the other ingredients
のレポートでは、におけるミルセラ（メトキシポリエチレングリコール - エポエチンベータ）（Mircera (methoxy polyethylene glycol-epoetin beta)）のとのをめることでミルセラ（メトキシポリエチレングリコール - エポエチンベータ）にわるいの
Mircera (methoxy polyethylene glycol-epoetin beta) 1 NAME OF THE MEDICINE Methoxy polyethylene glycol-epoetin beta 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Mircera 30 micrograms/0 3 mL solution for injection in pre-filled syringe Mircera 50 micrograms/0 3 mL solution for injection in pre-filled syringe
Sep 25 2017Generic Name: methoxy polyethylene glycol-epoetin beta Product Name: Mircera Indication: What Mircera is used for Mircera is used to treat anaemia caused by chronic kidney disease (kidney failure) Anaemia is a condition caused by low levels of red blood cells resulting in low haemoglobin a protein that transports oxygen in the blood
Hy cng YouMed tm hiểu v phn tch thuốc Mircera (methoxy polyethylene glycol epoetin beta) qua bi viết dưới đy! Tn thnh phần hoạt chất: methoxy polyethylene glycol epoetin beta (t dược: sodium phosphate monobasic monohydrate sodium sulphate mannitol methionine poloxamer 188 v nước cất pha tim)
Sep 25 2017Generic Name: methoxy polyethylene glycol-epoetin beta Product Name: Mircera Indication: What Mircera is used for Mircera is used to treat anaemia caused by chronic kidney disease (kidney failure) Anaemia is a condition caused by low levels of red blood cells resulting in low haemoglobin a protein that transports oxygen in the blood
Feb 01 2020Methoxy polyethylene glycol-epoetin beta injection causes the bone marrow to produce red blood cells If the body does not produce enough red blood cells severe anemia can occur This often occurs in people with chronic kidney failure whose kidneys are not working properly This medicine is available only with your doctor's prescription
MIRCERA is a medicine produced by gene-technology Like the natural hormone erythropoietin MIRCERA increases the number of red blood cells and haemoglobin level in your blood 2 What you need to know before you use MIRCERA Do not use MIRCERA • if you are allergic to methoxy polyethylene glycol-epoetin beta or to any of the other ingredients
Nov 14 2007Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Injectiion Company: Hoffman La-Roche Application No : 125164 Approval Date: 11/14/2007 Approval Letter(s) (PDF) Printed Labeling (PDF) Officer/Employee List (PDF) Office Director Memo (PDF) Medical Review(s) Part 1 (PDF) Part
Medscape - Anemia associated with chonic kidney disease dosing for Mircera (methoxy polyethylene glycol / epoetin beta) frequency-based adverse effects comprehensive interactions contraindications pregnancy lactation schedules and cost information
Methoxy polyethylene glycol-epoetin beta Retrieved April 17 2020 from MICROMEDEX Healthcare Series U S Food and Drug Administration (2018 June) Center for Drug Evaluation and Research Mircera (methoxy polyethylene glycol-epoetin beta) solution for injection: intravenous [IV] or subcutaneous [SC] use April 17 2020
Product: Mircera Manufacturer: Roche Generic: Epoetin beta methoxy polyethylene glycol Type: Injection Strength: 100 mcg/0 3 ml Packing: Pre-filled syringe Description: It aids the body create red blood cells Indication: This drug is indicated to treat anemia in chronic kidney disease patients
DESCRIPTION Mircera methoxy polyethylene glycol-epoetin beta is an ESA which differs from erythropoietin through formation of a chemical bond between either the N-terminal amino group or the ε-amino group of any lysine present in erythropoietin predominantly Lys 52 and Lys 45 and methoxy polyethylene glycol (PEG) butanoic acid (approximately 30 000 daltons)
A third-generation erythropoietic beta molecule created by integrating a large polymer chain into the molecule thus increasing the molecular weight to twice that of epoetin at approximately 60 kDa the methoxy-polyethylene glycol polymer chain is integrated via amide bonds between the N-terminal amino group or the e-amino group of lysine (predominantly lysine-52 or lysine-45) using a single
Methoxy polyethylene glycol-epoetin beta is the active ingredient of a drug marketed by Hoffmann-La Roche under the brand name Mircera Mircera is a long-acting erythropoietin receptor activator (CERA) indicated for the treatment of patients with anaemia associated with chronic kidney disease It is the first approved chemically modified erythropoiesis-stimulating agent (ESA)
lr3uxn0193 - methoxy polyethylene glycol-epoetin beta Η εποετίνη βήτα (epoetin beta) διεγείρει την ερυθροποίηση μέσω αλληλεπίδρασης με τον υποδοχέα της ερυθροποιητίνης στα προγονικά κύτταρα του μυελού των οστών
Apr 27 2020Note: This document contains side effect information about epoetin beta-methoxy polyethylene glycol Some of the dosage forms listed on this page may not apply to the brand name Mircera In Summary Common side effects of Mircera include: death Other side effects include: upper respiratory tract infection See below for a comprehensive list of adverse effects
Dec 15 2017MIRCERA- methoxy polyethylene glycol-epoetin beta injection solution Genentech Inc WARNINGS: ESAs INCREASE THE RISK OF DEATH MYOCARDIAL INFARCTION STROKE VENOUS THROMBOEMBOLISM THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
MIRCERA (methoxy polyethylene glycol-epoetin beta) injection for intravenous or subcutaneous use Initial U S Approval: 2007 WARNINGS: ESAs INCREASE THE RISK OF DEATH MYOCARDIAL INFARCTION STROKE VENOUS THROMBOEMBOLISM THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE
Methoxy polyethylene glycolepoetin beta (- Mircera) is a chemically synthesized continuous erythropoietin receptor activator Mircera differs from erythropoietin (EPO) through integration of an amide bond between an amino group and methoxy polyethylene glycol-butanoic acid This results in a molecular weight of ~60 kDa
Jun 22 2018Mircera is a prescription medication used to treat anemia associated with chronic kidney disease including patients on dialysis and patients not on dialysis Anemia is a condition that develops when your blood lacks enough healthy red blood cells Erythropoietin a primary growth factor for red blood cell production is produced in the kidney and released into the bloodstream
china custom logo designed kn95 kids anti dust
standard test methods for physical testing of
cdc - niosh publications and products - safety checklist
infectious disease 鈥 kentucky emergency
curad cast protectors - jc home medical
la grange aux lapins - lilo - moteur de recherche
pcb standards for the design of medical electronic
united steelworkers local 11-00418 3m cottage
china fpm full automatic 3 ply surgical disposable
non woven hood protective hair net hat disposable
pharmaceutical distributors directory
amid surge in coronavirus cases and mounting
national information resources on covid-19
new 2020 products n95 8210 mask Colombia medical face
china good quality disposable nitrile rubber gloves
lot masques de protection prime bleu - rutilisable
maryland general assembly - legislature
sales marketing manager - zouping huaqiang nonwoven co
china disposable nonwoven boots manufacturers
global spunbond nonwoven market insights and
covid-19 updates and resources - seiu healthcare
44 lovely photograph of ralph lauren size chart
stricter regulation following brexit will hurt uk
where to buy cute cloth masks for kids and adults and